Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC Trial

INTRODUCTION: Despite recent advances in NSCLC treatment, specific data on the elderly population remain limited. In this post hoc subgroup analysis of the East Asia S-1 Trial in Lung Cancer (EAST-LC) trial, we compared S-1 and docetaxel (DTX) in patients aged 70 years old and above with pretreated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474214/
https://www.ncbi.nlm.nih.gov/pubmed/34590001
http://dx.doi.org/10.1016/j.jtocrr.2021.100142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474214/
https://www.ncbi.nlm.nih.gov/pubmed/34590001
http://dx.doi.org/10.1016/j.jtocrr.2021.100142

Ejemplares similares